Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

NCT05135442 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Thrombotic Thrombocytopenic Purpura, Acquired

Interventions

DRUG: Bortezomib Injection

Sponsor

Peking Union Medical College Hospital